These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19846946)

  • 1. Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin.
    Hsieh TC; Wu JM
    Anticancer Res; 2009 Oct; 29(10):4025-32. PubMed ID: 19846946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
    Hsieh TC; Wu JM
    Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells.
    Bhatia N; Agarwal R
    Prostate; 2001 Feb; 46(2):98-107. PubMed ID: 11170137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proliferation and expression of AR/PSA by herbal supplement Equiguard in LNCaP cells cultured in androgen-proficient FBS and androgen-deficient charcoal-stripped FBS is correlated with increased serine-15 phosphorylation of the tumor suppressor gene p53.
    Lu X; Guo J; Hsieh TC; Wu JM
    Anticancer Res; 2003; 23(3B):2489-98. PubMed ID: 12894532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells.
    Wang P; Heber D; Henning SM
    Nutr Cancer; 2012; 64(4):580-7. PubMed ID: 22452782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanolic extracts of herbal supplement Equiguard suppress growth and control gene expression in CWR22Rv1 cells representing the transition of prostate cancer from androgen dependence to hormone refractory status.
    Hsieh TC; Wu JM
    Int J Oncol; 2008 Jan; 32(1):209-19. PubMed ID: 18097561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA.
    Johnson MK; Loo G
    Mutat Res; 2000 Apr; 459(3):211-8. PubMed ID: 10812333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
    Agarwal R
    Biochem Pharmacol; 2000 Oct; 60(8):1051-9. PubMed ID: 11007941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines.
    Burich RA; Holland WS; Vinall RL; Tepper C; White RW; Mack PC
    BJU Int; 2008 Nov; 102(10):1458-66. PubMed ID: 18565171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
    Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
    Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer.
    Kumar R; Verma V; Jain A; Jain RK; Maikhuri JP; Gupta G
    J Nutr Biochem; 2011 Aug; 22(8):723-31. PubMed ID: 21062672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activities of genistein-topotecan combination in prostate cancer cells.
    Hörmann V; Kumi-Diaka J; Durity M; Rathinavelu A
    J Cell Mol Med; 2012 Nov; 16(11):2631-6. PubMed ID: 22452992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth.
    Ping SY; Hour TC; Lin SR; Yu DS
    Urol Oncol; 2010; 28(2):170-9. PubMed ID: 18818108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
    Eom DW; Lee JH; Kim YJ; Hwang GS; Kim SN; Kwak JH; Cheon GJ; Kim KH; Jang HJ; Ham J; Kang KS; Yamabe N
    BMB Rep; 2015 Aug; 48(8):461-6. PubMed ID: 25441423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization to docetaxel in prostate cancer cells by green tea and quercetin.
    Wang P; Henning SM; Heber D; Vadgama JV
    J Nutr Biochem; 2015 Apr; 26(4):408-15. PubMed ID: 25655047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic cell death by EGCG and ibuprofen in DU-145 prostate cancer cell line.
    Kim MH; Chung J
    Anticancer Res; 2007; 27(6B):3947-56. PubMed ID: 18225555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.
    Moiseeva EP; Almeida GM; Jones GD; Manson MM
    Mol Cancer Ther; 2007 Nov; 6(11):3071-9. PubMed ID: 18025290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
    Moon YJ; Morris ME
    Mol Pharm; 2007; 4(6):865-72. PubMed ID: 17970592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
    Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate.
    Lambert JD; Kwon SJ; Ju J; Bose M; Lee MJ; Hong J; Hao X; Yang CS
    Carcinogenesis; 2008 Oct; 29(10):2019-24. PubMed ID: 18684728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.